» Articles » PMID: 38653563

Recent Update on Acute Kidney Injury-to-Chronic Kidney Disease Transition

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2024 Apr 23
PMID 38653563
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is characterized by an abrupt decline of excretory kidney function. The incidence of AKI has increased in the past decades. Patients diagnosed with AKI often undergo diverse clinical trajectories, such as early or late recovery, relapses, and even a potential transition from AKI to chronic kidney disease (CKD). Although recent clinical studies have demonstrated a strong association between AKI and progression of CKD, our understanding of the complex relationship between AKI and CKD is still evolving. No cohort study has succeeded in painting a comprehensive picture of these multi-faceted pathways. To address this lack of understanding, the idea of acute kidney disease (AKD) has recently been proposed. This presents a new perspective to pinpoint a period of heightened vulnerability following AKI, during which a patient could witness a substantial decline in glomerular filtration rate, ultimately leading to CKD transition. Although AKI is included in a range of kidney conditions collectively known as AKD, spanning from mild and self-limiting to severe and persistent, AKD can also occur without a rapid onset usually seen in AKI, such as when kidney dysfunction slowly evolves. In the present review, we summarize the most recent findings about AKD, explore the current state of biomarker discovery related to AKD, discuss the latest insights into pathophysiological underpinnings of AKI to CKD transition, and reflect on therapeutic challenges and opportunities that lie ahead.

Citing Articles

Alpha-lipoic acid: A promising pharmacotherapy seen through the lens of kidney diseases.

Dugbartey G, Alornyo K, Dapaa-Addo C, Botchway E, Kwashie E, Harley Y Curr Res Pharmacol Drug Discov. 2024; 7:100206.

PMID: 39524210 PMC: 11550178. DOI: 10.1016/j.crphar.2024.100206.


Caloric and time restriction diets improve acute kidney injury in experimental menopausal rats: role of silent information regulator 2 homolog 1 and transforming growth factor beta 1.

Darvishzadeh Mahani F, Raji-Amirhasani A, Khaksari M, Mousavi M, Bashiri H, Hajializadeh Z Mol Biol Rep. 2024; 51(1):812.

PMID: 39007943 DOI: 10.1007/s11033-024-09716-x.

References
1.
Canaud G, Bonventre J . Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. Nephrol Dial Transplant. 2014; 30(4):575-83. PMC: 4370290. DOI: 10.1093/ndt/gfu230. View

2.
Bhatia D, Capili A, Choi M . Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches. Kidney Res Clin Pract. 2020; 39(3):244-258. PMC: 7530368. DOI: 10.23876/j.krcp.20.082. View

3.
Sawhney S, Fluck N, Fraser S, Marks A, Prescott G, Roderick P . KDIGO-based acute kidney injury criteria operate differently in hospitals and the community-findings from a large population cohort. Nephrol Dial Transplant. 2016; 31(6):922-9. PMC: 4876971. DOI: 10.1093/ndt/gfw052. View

4.
Maekawa H, Inoue T, Ouchi H, Jao T, Inoue R, Nishi H . Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury. Cell Rep. 2019; 29(5):1261-1273.e6. DOI: 10.1016/j.celrep.2019.09.050. View

5.
Khalil R, Elghadban H, Abdelsalam M, Tawfik M . Kidney injury molecule-1: A potential marker of renal recovery after laparoscopic sleeve gastrectomy. Kidney Res Clin Pract. 2020; 39(2):162-171. PMC: 7321680. DOI: 10.23876/j.krcp.19.109. View